ioQuanta Research Desk

ioQuanta Research Desk is the editorial team behind ioQuanta research notes and progress tracking. It works from primary or near-primary sources, classifies evidence level and progress stage, and connects updates to longer research tracks when the evidence supports a meaningful link.

Read our Editorial Methodology →

Evidence date · Dec 18, 2021

How gut microbes could influence skin cells that stop dividing

Review or Meta-Analysis
Explore a proposed gut-to-skin pathway, what bacterial compounds and fiber changed in experiments, and why a skin-aging treatment remains unproven.
Evidence date · Aug 12, 2021

After an oxygen shortage, creatine-treated fetal sheep showed a delayed response

Peer-Reviewed Paper
Fetal sheep received creatine by infusion, not maternal supplements. Explore three-day oxygen changes and why brain protection remains unresolved.
Evidence date · Jan 1, 2026

How aging changes lung defenses and the prevention of severe infection

Review or Meta-Analysis
A review explains how aging changes lung defenses, why adapted vaccines can help, and what biomarkers and mouse studies can tell us about infection risk.
Evidence date · May 28, 2021

A gel combines structural support and drug delivery in injured rat spinal cords

Peer-Reviewed Paper
How an experimental gel re-forms, releases curcumin and supports nerve insulation—and what movement tests in rats reveal about spinal cord repair.
Evidence date · Aug 5, 2022

Bringing digital care tools together around older people’s needs

Clinical Trial
Explore a 2022 proposal to connect digital tools for early detection and care, and why its ambitions do not establish benefits for older people.
Evidence date · Jun 1, 2026

How brain changes help explain differences in Alzheimer’s symptoms

Review or Meta-Analysis
Explore what Alzheimer's tests detect, how brain changes relate to symptoms, and why matching treatments to disease profiles still needs validation.
Evidence date · Feb 8, 2026

What engineered immune cells recognize in cells that stop dividing

Review or Meta-Analysis
Engineered T cells can kill senescent cells in culture, but benefits for age-associated disease remain unproven in people.
Evidence date · Jan 31, 2026

Why cells left in growth arrest after cancer therapy may become treatment targets

Review or Meta-Analysis
A review of 36 animal studies explains how targeting cells left after cancer therapy affects tumor size and survival—and why some combinations fail.
Evidence date · Apr 3, 2025

How tumors leave immune cells less able to fight and multiply

Review or Meta-Analysis
A review examines why restoring exhausted T cells may not be enough to sustain attacks on cancer, and why targeting senescent cells still needs clinical testing.
Evidence date · Jun 1, 2026

How transplantation can change a child’s immune defenses and later cancer vulnerability

Review or Meta-Analysis
A review explores how immune defenses rebuild after transplantation, what cancer figures mean, and what would make immune testing useful for safer care.